RT @cochrane_hm: #Cochrane Review suggests infusion of mesenchymal stromal cells in patients with blood disorders who underwent haematopoie…
RT @cochrane_hm: #Cochrane Review suggests infusion of mesenchymal stromal cells in patients with blood disorders who underwent haematopoie…
Stem Cell Evidence Alert this month includes SRI's #Cochrane review on mesenchymal stromal cells to prevent or treat #GVHD https://t.co/TZIecIs2YR #hematology
RT @cochrane_hm: #Cochrane Review suggests infusion of mesenchymal stromal cells in patients with blood disorders who underwent haematopoie…
Mesenchymal stromal cells or prophylaxis for acute or chronic graft‐versus‐host disease in HSCT recipients with a haematological condition: Evidence to date from RCTs does not support MSCs as an effective therapy | https://t.co/07unfL2X84 #childhealth http
RT @cochrane_hm: #Cochrane Review suggests infusion of mesenchymal stromal cells in patients with blood disorders who underwent haematopoie…
#Cochrane Review suggests infusion of mesenchymal stromal cells in patients with blood disorders who underwent haematopoietic stem cell transplantation to be well-tolerated and safe (https://t.co/TJFTe0ZKzi). #cochraneevidence #blogshot #hematology https:/
New #CochraneEvidence: Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition | https://t.co/07unfLkywE #childhealth http
Mesenchymal stromal cells to treat or prevent graft-versus-host disease in stem cell transplant recipients https://t.co/aFWN67HMHg